Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Avantor price target lowered to $27 from $29 at Baird » 06:51
02/06/23
02/06
06:51
02/06/23
06:51
AVTR

Avantor

/

+

Baird analyst Catherine…

Baird analyst Catherine Schulte lowered the firm's price target on Avantor to $27 from $29 and keeps an Outperform rating on the shares. The analyst noted they reported generally inline Q4 results and while the business faces some COVID/destocking headwinds in 1H, we think underlying demand is healthier than appreciated and believe sentiment could improve in 2H23/into 2024.

ShowHide Related Items >><<
AVTR Avantor
/

+

AVTR Avantor
/

+

02/06/23 Citi
Avantor price target raised to $30 from $25 at Citi
02/05/23 Raymond James
Avantor price target raised to $30 from $26 at Raymond James
01/24/23 Barclays
Avantor price target raised to $26 from $23 at Barclays
12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
AVTR Avantor
/

+

AVTR Avantor
/

+

Recommendations
Avantor price target raised to $30 from $25 at Citi » 06:34
02/06/23
02/06
06:34
02/06/23
06:34
AVTR

Avantor

$23.06 /

-1.84 (-7.39%)

Citi analyst Patrick…

Citi analyst Patrick Donnelly raised the firm's price target on Avantor to $30 from $25 and keeps a Buy rating on the shares post the Q4 results. The analyst believes management took a more conservative approach to its Q1 core organic revenue growth guidance. It cites improving messaging and management execution for the target bump.

ShowHide Related Items >><<
AVTR Avantor
$23.06 /

-1.84 (-7.39%)

AVTR Avantor
$23.06 /

-1.84 (-7.39%)

02/05/23 Raymond James
Avantor price target raised to $30 from $26 at Raymond James
01/24/23 Barclays
Avantor price target raised to $26 from $23 at Barclays
12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
AVTR Avantor
$23.06 /

-1.84 (-7.39%)

AVTR Avantor
$23.06 /

-1.84 (-7.39%)

Sunday
Recommendations
Avantor price target raised to $30 from $26 at Raymond James » 20:45
02/05/23
02/05
20:45
02/05/23
20:45
AVTR

Avantor

$23.06 /

-1.84 (-7.39%)

Raymond James analyst…

Raymond James analyst Andrew Cooper raised the firm's price target on Avantor to $30 from $26 and keeps an Outperform rating on the shares post the Q4 results. The analyst expects the stock "may take a pause" until greater evidence of sequential improvement is generated through the year. The firm, however, views the stock's risk/reward positively.

ShowHide Related Items >><<
AVTR Avantor
$23.06 /

-1.84 (-7.39%)

AVTR Avantor
$23.06 /

-1.84 (-7.39%)

01/24/23 Barclays
Avantor price target raised to $26 from $23 at Barclays
12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
AVTR Avantor
$23.06 /

-1.84 (-7.39%)

AVTR Avantor
$23.06 /

-1.84 (-7.39%)

Friday
Earnings
Avantor reports Q4 adjusted EPS 32c, consensus 30c » 06:12
02/03/23
02/03
06:12
02/03/23
06:12
AVTR

Avantor

$24.90 /

+0.455 (+1.86%)

Reports Q4 revenue $1.8B,…

Reports Q4 revenue $1.8B, consensus $1.8B. "With fourth quarter results coming in line with expectations outlined on our third quarter earnings call, we realized core organic growth across all regions and delivered strong margin expansion despite ongoing macroeconomic pressures and customer destocking. Our full-year results reflect the strength and resilience of our core business, with 6% core organic growth including more than 20% core organic growth in bioproduction, approximately 110 basis points of adjusted EBITDA margin expansion, and a double-digit increase in adjusted net income on a constant currency basis," said Michael Stubblefield, president and CEO.

ShowHide Related Items >><<
AVTR Avantor
$24.90 /

+0.455 (+1.86%)

AVTR Avantor
$24.90 /

+0.455 (+1.86%)

01/24/23 Barclays
Avantor price target raised to $26 from $23 at Barclays
12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
AVTR Avantor
$24.90 /

+0.455 (+1.86%)

AVTR Avantor
$24.90 /

+0.455 (+1.86%)

Over a week ago
Recommendations
Avantor price target raised to $26 from $23 at Barclays » 05:12
01/24/23
01/24
05:12
01/24/23
05:12
AVTR

Avantor

$23.65 /

+0.64 (+2.78%)

Barclays analyst Luke…

Barclays analyst Luke Sergott raised the firm's price target on Avantor to $26 from $23 and keeps an Overweight rating on the shares. The analyst says 2023 will likely be a "tale of 2 cities" for traditional tools verses bioprocessing names. The year likely favors conservative management teams with a history of beating estimates, the firm tells investors in a research note.

ShowHide Related Items >><<
AVTR Avantor
$23.65 /

+0.64 (+2.78%)

AVTR Avantor
$23.65 /

+0.64 (+2.78%)

12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
10/31/22 Wells Fargo
Avantor price target lowered to $27 from $33 at Wells Fargo
AVTR Avantor
$23.65 /

+0.64 (+2.78%)

AVTR Avantor
$23.65 /

+0.64 (+2.78%)

AVTR Avantor
$23.65 /

+0.64 (+2.78%)

Hot Stocks
Avantor, Catalent enter multi-year supply agreement » 07:32
01/09/23
01/09
07:32
01/09/23
07:32
AVTR

Avantor

$20.07 /

-0.585 (-2.83%)

, CTLT

Catalent

$47.67 /

+1.495 (+3.24%)

Avantor (AVTR) announced…

Avantor (AVTR) announced that it has entered into a multi-year supply and services agreement with Catalent (CTLT). Under the terms of the agreement, Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies' existing relationship.

ShowHide Related Items >><<
CTLT Catalent
$47.67 /

+1.495 (+3.24%)

AVTR Avantor
$20.07 /

-0.585 (-2.83%)

AVTR Avantor
$20.07 /

-0.585 (-2.83%)

12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
10/31/22 Wells Fargo
Avantor price target lowered to $27 from $33 at Wells Fargo
CTLT Catalent
$47.67 /

+1.495 (+3.24%)

12/19/22 KeyBanc
Catalent downgraded to Sector Weight from Overweight at KeyBanc
12/08/22 Baird
Catalent short report doesn't raise new topics, says Baird
11/28/22 Morgan Stanley
Catalent VAI update addresses Brussels shutdown concerns, says Morgan Stanley
11/28/22 Barclays
Catalent had 483s cleared, removing overhang, says Barclays
CTLT Catalent
$47.67 /

+1.495 (+3.24%)

AVTR Avantor
$20.07 /

-0.585 (-2.83%)

CTLT Catalent
$47.67 /

+1.495 (+3.24%)

CTLT Catalent
$47.67 /

+1.495 (+3.24%)

AVTR Avantor
$20.07 /

-0.585 (-2.83%)

CTLT Catalent
$47.67 /

+1.495 (+3.24%)

AVTR Avantor
$20.07 /

-0.585 (-2.83%)

Over a month ago
Hot Stocks
MamaMancini's appoints Henson to board of directors » 08:44
12/19/22
12/19
08:44
12/19/22
08:44
MMMB

MamaMancini’s

$1.34 /

-0.09 (-6.29%)

, AVTR

Avantor

$20.72 /

-0.625 (-2.93%)

MamaMancini's (MMMB)…

MamaMancini's (MMMB) announced the appointment of human resources executive Meghan Henson to its Board of Directors. Meghan Henson is a senior executive with over 20 years of experience as a versatile human resources professional, leading HR strategy and execution at leading global organizations. Henson is currently Executive Vice President and Chief Human Resources Officer at Avantor (AVTR)

ShowHide Related Items >><<
MMMB MamaMancini’s
$1.34 /

-0.09 (-6.29%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

MMMB MamaMancini’s
$1.34 /

-0.09 (-6.29%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
10/31/22 Wells Fargo
Avantor price target lowered to $27 from $33 at Wells Fargo
AVTR Avantor
$20.72 /

-0.625 (-2.93%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

On The Fly
Buy/Sell: Wall Street's top 10 stock calls this week » 08:23
12/17/22
12/17
08:23
12/17/22
08:23
TPR

Tapestry

$36.61 /

-0.69 (-1.85%)

, GPS

Gap

$12.93 /

-0.14 (-1.07%)

, CRWD

Crowdstrike

$111.48 /

-3.51 (-3.05%)

, UAA

Under Armour

$10.13 /

+0.09 (+0.90%)

, UA

Under Armour

$8.79 /

+0.04 (+0.46%)

, LRCX

Lam Research

$443.72 /

-2.36 (-0.53%)

, PINS

Pinterest

$24.79 /

-0.365 (-1.45%)

, QCOM

Qualcomm

$114.54 /

-2.065 (-1.77%)

, AAPL

Apple

$134.51 /

-1.93 (-1.41%)

, WDC

Western Digital

$31.92 /

-0.295 (-0.92%)

, EL

Estee Lauder

$240.86 /

+0.15 (+0.06%)

, DFS

Discover

$96.92 /

-1.85 (-1.87%)

, BIO

Bio-Rad

$408.14 /

-12.12 (-2.88%)

, PKI

PerkinElmer

$137.70 /

-3.34 (-2.37%)

, AVTR

Avantor

$20.72 /

-0.625 (-2.93%)

, QDEL

QuidelOrtho

$82.56 /

-3.505 (-4.07%)

, ICLR

Icon

$187.10 /

-3.53 (-1.85%)

, ILMN

Illumina

$199.46 /

-8.06 (-3.88%)

, COF

Capital One

$90.10 /

-3.7 (-3.94%)

What has Wall Street been…

ShowHide Related Items >><<
WDC Western Digital
$31.92 /

-0.295 (-0.92%)

UAA Under Armour
$10.13 /

+0.09 (+0.90%)

TPR Tapestry
$36.61 /

-0.69 (-1.85%)

QDEL QuidelOrtho
$82.56 /

-3.505 (-4.07%)

QCOM Qualcomm
$114.54 /

-2.065 (-1.77%)

PKI PerkinElmer
$137.70 /

-3.34 (-2.37%)

PINS Pinterest
$24.79 /

-0.365 (-1.45%)

LRCX Lam Research
$443.72 /

-2.36 (-0.53%)

ILMN Illumina
$199.46 /

-8.06 (-3.88%)

ICLR Icon
$187.10 /

-3.53 (-1.85%)

GPS Gap
$12.93 /

-0.14 (-1.07%)

EL Estee Lauder
$240.86 /

+0.15 (+0.06%)

DFS Discover
$96.92 /

-1.85 (-1.87%)

CRWD Crowdstrike
$111.48 /

-3.51 (-3.05%)

COF Capital One
$90.10 /

-3.7 (-3.94%)

BIO Bio-Rad
$408.14 /

-12.12 (-2.88%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

AAPL Apple
$134.51 /

-1.93 (-1.41%)

TPR Tapestry
$36.61 /

-0.69 (-1.85%)

12/13/22 Morgan Stanley
Nike price target raised to $127 from $120 at Morgan Stanley
12/12/22 Goldman Sachs
Tapestry upgraded to Buy from Neutral at Goldman Sachs
11/29/22 JPMorgan
Tapestry price target raised to $47 from $46 at JPMorgan
11/14/22 Citi
Tapestry price target lowered to $40 from $42 at Citi
GPS Gap
$12.93 /

-0.14 (-1.07%)

12/12/22 Goldman Sachs
Gap upgraded to Buy from Neutral at Goldman Sachs
11/21/22 Deutsche Bank
Gap price target raised to $11 from $8 at Deutsche Bank
11/21/22 Barclays
Gap price target raised to $14 from $9 at Barclays
11/18/22 Jefferies
Gap price target raised to $13 from $11 at Jefferies
CRWD Crowdstrike
$111.48 /

-3.51 (-3.05%)

12/15/22 Wedbush
Wedbush bullish on Crowdstrike, initiates with an Outperform
12/14/22 Wedbush
Crowdstrike initiated with an Outperform at Wedbush
12/09/22 BTIG
Datadog price target lowered to $93 from $104 at BTIG
12/07/22 Deutsche Bank
SentinelOne price target lowered to $20 from $32 at Deutsche Bank
UAA Under Armour
$10.13 /

+0.09 (+0.90%)

12/12/22 Stifel
Under Armour upgraded to Buy from Hold at Stifel
11/07/22 JPMorgan
Under Armour price target raised to $11 from $10 at JPMorgan
11/01/22 BofA
Under Armour reinstated with a Neutral at BofA
10/31/22 JPMorgan
Under Armour price target lowered to $10 from $12 at JPMorgan
UA Under Armour
$8.79 /

+0.04 (+0.46%)

LRCX Lam Research
$443.72 /

-2.36 (-0.53%)

12/15/22 Morgan Stanley
AMD named 'Top Pick' in Semiconductors at Morgan Stanley
12/12/22 Deutsche Bank
Lam Research upgraded to Buy from Hold at Deutsche Bank
10/20/22 Jefferies
Lam Research price target lowered to $525 from $535 at Jefferies
10/20/22 Evercore ISI
Lam Research price target lowered to $450 from $500 at Evercore ISI
PINS Pinterest
$24.79 /

-0.365 (-1.45%)

12/13/22 Piper Sandler
Pinterest upgraded to Overweight from Neutral at Piper Sandler
10/31/22 Citi
Pinterest price target raised to $26 from $25 at Citi
10/28/22 Stifel
Pinterest 'a rare bright spot thus far through earnings,' says Stifel
10/28/22 Barclays
Pinterest price target raised to $25 from $23 at Barclays
QCOM Qualcomm
$114.54 /

-2.065 (-1.77%)

12/12/22 Wells Fargo
Wells Fargo downgrades Qualcomm to Underweight with $105 price target
12/12/22 Wells Fargo
Qualcomm downgraded to Underweight from Equal Weight at Wells Fargo
11/15/22 Credit Suisse
Qualcomm initiated with an Outperform at Credit Suisse
11/03/22 KeyBanc
Qualcomm price target lowered to $150 from $170 at KeyBanc
AAPL Apple
$134.51 /

-1.93 (-1.41%)

12/14/22 Morgan Stanley
Morgan Stanley sees 'limited risk' to Apple App Store revenue from competition
12/14/22 Evercore ISI
Evercore sees 'minimal impact' to Apple from reported App Store overhaul
12/13/22 Piper Sandler
Report of Apple exploring alternative app stores positive for Match, says Piper
12/12/22 Oppenheimer
Apple price target lowered to $170 from $190 at Oppenheimer
WDC Western Digital
$31.92 /

-0.295 (-0.92%)

12/15/22 Goldman Sachs
Western Digital downgraded to Sell from Neutral at Goldman Sachs
11/29/22 Mizuho
Western Digital price target lowered to $38 from $40 at Mizuho
10/31/22 Citi
Western Digital price target lowered to $45 from $60 at Citi
10/31/22 Baird
Western Digital price target lowered to $50 from $55 at Baird
EL Estee Lauder
$240.86 /

+0.15 (+0.06%)

12/15/22 Redburn
Redburn starts Estee Lauder at Sell with China reopening priced in
12/15/22 Redburn
Estee Lauder initiated with a Sell at Redburn
12/13/22 JPMorgan
Estee Lauder price target raised to $274 from $220 at JPMorgan
12/06/22 Deutsche Bank
Estee Lauder upgraded to Buy from Hold at Deutsche Bank
DFS Discover
$96.92 /

-1.85 (-1.87%)

12/15/22 Wells Fargo
Discover price target raised to $115 from $103 at Wells Fargo
12/13/22 BofA
Synchrony downgraded to Neutral at BofA on consumer concerns
12/13/22 BofA
Discover double downgraded to Underperform at BofA on consumer concerns
12/13/22 BofA
Discover downgraded to Underperform from Buy at BofA
BIO Bio-Rad
$408.14 /

-12.12 (-2.88%)

12/06/22 RBC Capital
Bio-Rad initiated with an Outperform at RBC Capital
10/11/22 Jefferies
Jefferies 'not surprised' by report of Bio-Rad talks to combine with Qiagen
08/24/22 Credit Suisse
Bio-Rad initiated with an Outperform at Credit Suisse
07/08/22 Citi
Bio-Rad price target lowered to $700 from $750 at Citi
PKI PerkinElmer
$137.70 /

-3.34 (-2.37%)

12/12/22 Citi
PerkinElmer upgraded to Buy from Neutral at Citi
12/12/22 Citi
PerkinElmer upgraded to Buy from Neutral at Citi
12/06/22 Cowen
PerkinElmer upgraded to Outperform from Market Perform at Cowen
11/28/22 Barclays
PerkinElmer upgraded to Equal Weight from Underweight at Barclays
AVTR Avantor
$20.72 /

-0.625 (-2.93%)

12/13/22 Deutsche Bank
Avantor initiated with a Hold at Deutsche Bank
10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
10/31/22 Wells Fargo
Avantor price target lowered to $27 from $33 at Wells Fargo
QDEL QuidelOrtho
$82.56 /

-3.505 (-4.07%)

12/12/22 Citi
QuidelOrtho upgraded to Buy from Neutral at Citi
12/06/22 RBC Capital
QuidelOrtho initiated with an Outperform at RBC Capital
10/14/22 UBS
QuidelOrtho upgraded to Neutral from Sell at UBS
09/19/22 Citi
QuidelOrtho initiated with a Neutral at Citi
ICLR Icon
$187.10 /

-3.53 (-1.85%)

11/09/22 BofA
Icon upgraded to Buy from Neutral at BofA
10/18/22 Deutsche Bank
Icon price target lowered to $280 from $295 at Deutsche Bank
10/10/22 Guggenheim
Iqvia price target lowered to $234 from $246 at Guggenheim
10/10/22 Guggenheim
Icon price target lowered to $268 from $278 at Guggenheim
ILMN Illumina
$199.46 /

-8.06 (-3.88%)

12/12/22 Citi
Illumina downgraded to Sell from Neutral at Citi
12/12/22 Citi
Illumina downgraded to Sell from Neutral at Citi
12/06/22 RBC Capital
Illumina initiated with an Outperform at RBC Capital
12/06/22 Canaccord
Illumina divestment for GRAIL buy worth the wait, says Canaccord
COF Capital One
$90.10 /

-3.7 (-3.94%)

12/12/22 JPMorgan
Capital One added to Analyst Focus List at JPMorgan
12/01/22 Wolfe Research
Capital One price target raised to $81 from $77 at Wolfe Research
WDC Western Digital
$31.92 /

-0.295 (-0.92%)

UAA Under Armour
$10.13 /

+0.09 (+0.90%)

TPR Tapestry
$36.61 /

-0.69 (-1.85%)

QDEL QuidelOrtho
$82.56 /

-3.505 (-4.07%)

QCOM Qualcomm
$114.54 /

-2.065 (-1.77%)

PKI PerkinElmer
$137.70 /

-3.34 (-2.37%)

PINS Pinterest
$24.79 /

-0.365 (-1.45%)

LRCX Lam Research
$443.72 /

-2.36 (-0.53%)

ILMN Illumina
$199.46 /

-8.06 (-3.88%)

ICLR Icon
$187.10 /

-3.53 (-1.85%)

GPS Gap
$12.93 /

-0.14 (-1.07%)

EL Estee Lauder
$240.86 /

+0.15 (+0.06%)

DFS Discover
$96.92 /

-1.85 (-1.87%)

CRWD Crowdstrike
$111.48 /

-3.51 (-3.05%)

COF Capital One
$90.10 /

-3.7 (-3.94%)

BIO Bio-Rad
$408.14 /

-12.12 (-2.88%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

AAPL Apple
$134.51 /

-1.93 (-1.41%)

UAA Under Armour
$10.13 /

+0.09 (+0.90%)

TPR Tapestry
$36.61 /

-0.69 (-1.85%)

QCOM Qualcomm
$114.54 /

-2.065 (-1.77%)

PINS Pinterest
$24.79 /

-0.365 (-1.45%)

LRCX Lam Research
$443.72 /

-2.36 (-0.53%)

ILMN Illumina
$199.46 /

-8.06 (-3.88%)

GPS Gap
$12.93 /

-0.14 (-1.07%)

EL Estee Lauder
$240.86 /

+0.15 (+0.06%)

CRWD Crowdstrike
$111.48 /

-3.51 (-3.05%)

COF Capital One
$90.10 /

-3.7 (-3.94%)

BIO Bio-Rad
$408.14 /

-12.12 (-2.88%)

AAPL Apple
$134.51 /

-1.93 (-1.41%)

WDC Western Digital
$31.92 /

-0.295 (-0.92%)

UAA Under Armour
$10.13 /

+0.09 (+0.90%)

TPR Tapestry
$36.61 /

-0.69 (-1.85%)

QDEL QuidelOrtho
$82.56 /

-3.505 (-4.07%)

PKI PerkinElmer
$137.70 /

-3.34 (-2.37%)

PINS Pinterest
$24.79 /

-0.365 (-1.45%)

LRCX Lam Research
$443.72 /

-2.36 (-0.53%)

ILMN Illumina
$199.46 /

-8.06 (-3.88%)

ICLR Icon
$187.10 /

-3.53 (-1.85%)

GPS Gap
$12.93 /

-0.14 (-1.07%)

EL Estee Lauder
$240.86 /

+0.15 (+0.06%)

DFS Discover
$96.92 /

-1.85 (-1.87%)

CRWD Crowdstrike
$111.48 /

-3.51 (-3.05%)

COF Capital One
$90.10 /

-3.7 (-3.94%)

BIO Bio-Rad
$408.14 /

-12.12 (-2.88%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

AAPL Apple
$134.51 /

-1.93 (-1.41%)

WDC Western Digital
$31.92 /

-0.295 (-0.92%)

UAA Under Armour
$10.13 /

+0.09 (+0.90%)

TPR Tapestry
$36.61 /

-0.69 (-1.85%)

QCOM Qualcomm
$114.54 /

-2.065 (-1.77%)

PKI PerkinElmer
$137.70 /

-3.34 (-2.37%)

PINS Pinterest
$24.79 /

-0.365 (-1.45%)

LRCX Lam Research
$443.72 /

-2.36 (-0.53%)

ILMN Illumina
$199.46 /

-8.06 (-3.88%)

GPS Gap
$12.93 /

-0.14 (-1.07%)

EL Estee Lauder
$240.86 /

+0.15 (+0.06%)

DFS Discover
$96.92 /

-1.85 (-1.87%)

CRWD Crowdstrike
$111.48 /

-3.51 (-3.05%)

COF Capital One
$90.10 /

-3.7 (-3.94%)

AVTR Avantor
$20.72 /

-0.625 (-2.93%)

AAPL Apple
$134.51 /

-1.93 (-1.41%)

Initiation
Avantor initiated with a Hold at Deutsche Bank » 16:26
12/13/22
12/13
16:26
12/13/22
16:26
AVTR

Avantor

$22.01 /

+0.61 (+2.85%)

Deutsche Bank analyst…

Deutsche Bank analyst Justin Bowers initiated coverage of Avantor with a Hold rating and $24 price target. The analyst launched coverage of 10 life science tools companies that have "outsized exposure" to the biopharma end market. The stocks that outperform in 2023 "will provide downside protection or are idiosyncratic," Bowers tells investors in a research note. He recommends "captains of culture" Danaher (DHR) and Thermo Fisher Scientific (TMO) for more defensive posturing. Buy-rated rated Maravai Lifesciences (MRVI), Bio-Techne (TECH) and 10X Genomics (TXG) offer novel technology and have embedded optionality, Bowers tells investors in a research note. His Hold-rated names reflect wanting better entry points andconviction in consensus estimates.

ShowHide Related Items >><<
AVTR Avantor
$22.01 /

+0.61 (+2.85%)

AVTR Avantor
$22.01 /

+0.61 (+2.85%)

10/31/22 Citi
Avantor price target lowered to $25 from $28 at Citi
10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
10/31/22 Wells Fargo
Avantor price target lowered to $27 from $33 at Wells Fargo
10/31/22 Credit Suisse
Avantor price target lowered to $25 from $32 at Credit Suisse
AVTR Avantor
$22.01 /

+0.61 (+2.85%)

AVTR Avantor
$22.01 /

+0.61 (+2.85%)

AVTR Avantor
$22.01 /

+0.61 (+2.85%)

Over a quarter ago
Recommendations
Avantor price target lowered to $25 from $28 at Citi » 07:34
10/31/22
10/31
07:34
10/31/22
07:34
AVTR

Avantor

$19.21 /

-1.335 (-6.50%)

Citi analyst Patrick…

Citi analyst Patrick Donnelly lowered the firm's price target on Avantor to $25 from $28 and keeps a Buy rating on the shares. The company reduced its fiscal 2022 organic growth guidance, implying flat to low-single-digit organic growth in Q4, Donnelly tells investors in a research note. He views the guidance as slightly worse than anticipated but feels estimates "are now appropriately washed out, with a heavily discounted multiple making this an attractive entry point."

ShowHide Related Items >><<
AVTR Avantor
$19.21 /

-1.335 (-6.50%)

AVTR Avantor
$19.21 /

-1.335 (-6.50%)

10/31/22 Baird
Avantor price target lowered to $29 from $32 at Baird
10/31/22 Wells Fargo
Avantor price target lowered to $27 from $33 at Wells Fargo
10/31/22 Credit Suisse
Avantor price target lowered to $25 from $32 at Credit Suisse
10/31/22 Barclays
Avantor price target lowered to $23 from $25 at Barclays
AVTR Avantor
$19.21 /

-1.335 (-6.50%)

AVTR Avantor
$19.21 /

-1.335 (-6.50%)

AVTR Avantor
$19.21 /

-1.335 (-6.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.